Chronic cardiac failure in children due to dilated cardiomyopathy: Diagnostic approach, pathophysiology and management

European Journal of Pediatrics

Volumn 159, Issue 11, 2000, Pages 803-810

  Venugopalan, Poothirikovil ^a   Agarwal, Ajit Kumar ^a   Worthing, Elizabeth Ann ^a  

^a SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

Author keywords

Apoptosis; Beta blocker therapy; Concordance; Drug compliance; Myocardial remodelling

Indexed keywords

AMILORIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; ENALAPRIL; FUROSEMIDE; LOSARTAN; METOLAZONE; SPIRONOLACTONE;

ADRENERGIC SYSTEM; BETA ADRENERGIC RECEPTOR BLOCKING; CONGESTIVE HEART FAILURE; ECHOCARDIOGRAPHY; HEART DILATATION; HEART TRANSPLANTATION; HUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0033771799     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310000588     Document Type: Review

References (53)

1. Beneficial effects of 1-year captopril therapy in children with chronic aortic regurgitation who have no symptoms
2. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis
3. Therapeutic effect of taurine in congestive heart failure: A double-blind crossover trial
4. Tastes of liquid medications: Pediatric implications
5. Compliance with drug therapy
6. Automatic implantable cardioverter therapy: Lessons from the 1980s, expectations for the 1990s
7. Tumor necrosis factor-α and cardiomyopathy
8. Survival and risk factors for death after cardiac transplantation in infants. A multi-institutional study. The Pediatric Heart Transplant Study
9. Consensus recommendations for the management of chronic heart failure. On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure
10. Selection and treatment of candidates for heart transplantation
11. Dilated cardiomyopathy: An introduction to pathology and pathogenesis
12. Extracorporeal membrane oxygenation for cardiac support in children
13. The effect of digoxin on mortality and morbidity in patients with heart failure
14. Tumour necrosis factor-α in severe congestive cardiac failure
15. Stability of amiloride hydrochloride oral liquids prepared from tablets and powder
16. A preliminary study of growth hormone in the treatment of dilated cardiomyopathy
17. Propionyl-L-carnitine improves skeletal muscle metabolism and exercise capacity of patients with congestive heart failure
18. Children with congenital heart disease: A nutritional challenge
19. The benefits of prescription information leaflets
20. Home inotropic therapy in advanced heart failure. Cost analysis and clinical outcomes
21. Helping patients to make the best use of medicines
22. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure
23. Mechanical circulatory assistance in Pediatric patients with cardiac failure
24. Thyroid hormone and the cardiovascular system: From theory to practice
25. Diuretic treatment and diuretic resistance in heart failure
26. Long-term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy
27. Efficacy and dosage of enalapril in congenital and acquired heart disease
28. The effect of treatment with angiotensin-converting enzyme inhibitors on survival of pediatric patients with dilated cardiomyopathy
29. Perceptions by family members of the dying experience of older and seriously ill patients. SUPPORT Investigators. Study to understand prognoses and preferences for outcomes and risk of treatments
30. Clinical cardiomyoplasty: Review of the ten-year United States experience
31. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart Chest Lung and Blood Institute workshop)
32. Psychopathology of chronic diseases in children and adolescents. Congenital cardiomyopathies
33. Guidelines for the study of familial dilated cardiomyopathies
34. Congestive heart failure in children
35. Apoptosis in the failing human heart
36. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
37. Effects of vitamin E on the cardiac function and contractility in chronic volume-overload heart failure
38. Reduced desmopressin-nitric oxide mediated vasodilation in patients with heart failure
39. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies
40. Cardiovascular responses to exercise in children and adolescents with myocardial dysfunction
41. Neonatal hemodialysis: Effective therapy for the encephalopathy of inborn errors of metabolism
42. The effect of the first dose of captopril on blood pressure in infants in heart failure
43. Clinical approach to genetic cardiomyopathy in children
44. Beta-blocker therapy in young children with congestive heart failure under consideration for heart transplantation
45. Two-year experience of the Batista operation for non-ischaemic cardiomyopathy
46. Angiotensin II receptors and angiotensin II receptor antagonists
47. Pediatric myocardial disease
48. Unlicensed and off label drug use in paediatric wards: A prospective study
49. Improved prognosis of heart failure due to idiopathic dilated cardiomyopathy in children
50. Myocardial fibrosis: Functional significance and regulatory factors
51. The pharmacology and therapeutics of diuretics in the pediatric patient
52. Discrepancy between solution and bioavailability of digoxin tablets